Investor Presentaiton

6 Robust Financial Performance Robust financial performance with double digit top line and bottom line growth ibnsinapharma IN Net Revenues Gross Profit EGP 9.6 BN EGP 826 MN BNa EBITDA EGP 406 MN Net Profit inapharma EGP 170 MN Norm. Net Profit¹ EGP 207.1 MN ▲ 103.4% y-o-y ▲ 67.2% y-o-y ▲ 77.5% y-o-y ▲ 33% y-o-y ▲ 45.2% y-o-y ibnsinapharma Source: Company Management (1): Normalized net profit factors out ISP's one-time IPO expenses of EGP 15.0 million and a general provision of EGP 22.0 million, 17

View entire presentation